The women’s health devices market size has grown rapidly in recent years. It will grow from $44.2 billion in 2025 to $49.48 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to growing awareness of women’s health conditions, expansion of preventive healthcare programs, increasing availability of diagnostic devices, rising focus on maternal health management, adoption of digital health tools.
The women’s health devices market size is expected to see rapid growth in the next few years. It will grow to $77.08 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to increasing investments in femtech innovation, rising demand for personalized healthcare solutions, expansion of telehealth services, growing adoption of wearable health devices, increasing focus on data-driven women’s health insights. Major trends in the forecast period include increasing adoption of connected women’s health devices, rising use of at-home diagnostic kits, growing integration of digital health platforms, expansion of fertility and menstrual tracking solutions, enhanced focus on personalized women’s care.
The rising prevalence of chronic diseases is anticipated to support the expansion of the women’s health devices market in the coming years. Chronic diseases are long-term health conditions that last for extended periods, often develop gradually, negatively impact quality of life, and require continuous medical care, although they can generally be managed through appropriate treatment and lifestyle modifications. The growing burden of chronic diseases is largely attributed to increasingly sedentary lifestyles, which contribute to obesity, impaired metabolic health, and a higher risk of developing long-term medical conditions. Women’s health devices play an important role in addressing chronic conditions by supporting early diagnosis, ongoing monitoring, and customized management of disorders such as diabetes, cardiovascular diseases, and hormonal imbalances, thereby enhancing overall health outcomes and quality of life. For instance, in April 2025, according to a report published by the Centers for Disease Control and Prevention (CDC), a United States-based public health organization, in 2023, 76.4% of adults in the United States, or around 194 million people, reported having at least one chronic condition, with prevalence rates of 59.5% among young adults, 78.4% among middle-aged adults, and 93% among older adults. As a result, the increasing incidence of chronic diseases is contributing to the growth of the women’s health devices market.
Major players in the women’s health devices market are introducing smart rings to deliver medical-grade health data that can be converted into personalized insights for users. These smart rings are specifically developed for women and provide clinically relevant health information through a connected mobile application. For example, in January 2023, Movano Health, a United States-based medical device company, launched Evie, a women-focused smart ring designed to deliver medical-grade health insights via a dedicated app. Evie is developed in line with United States Food and Drug Administration regulatory standards and is manufactured in facilities compliant with International Organization for Standardization 13485 and current Good Manufacturing Practice requirements. The device tracks a wide range of health parameters, including heart rate, blood oxygen saturation (SpO₂), menstrual cycles, sleep patterns, and other metrics, which are displayed in a clear and user-friendly format within the application.
In October 2024, Hologic Inc., a United States-based healthcare technology company focused on women’s health devices, acquired Gynesonics Inc. for approximately $350 million. Through this acquisition, Hologic sought to strengthen its portfolio of minimally invasive gynecological solutions by incorporating an innovative transcervical fibroid treatment technology. Gynesonics Inc., a United States-based medical device company, specializes in the Sonata System, which integrates real-time intrauterine ultrasound imaging with targeted radiofrequency ablation to treat symptomatic uterine fibroids without the need for surgical incisions.
Major companies operating in the women’s health devices market are Abbott Laboratories, Koninklijke Philips N V, CooperSurgical Inc, Hologic Inc, Caldera Medical Inc, GE HealthCare Technologies Inc, Siemens Healthineers AG, Boston Scientific Corporation, Medtronic plc, Becton Dickinson And Company, Olympus Corporation, Fujifilm Holdings Corporation, Johnson And Johnson, Stryker Corporation, Smith And Nephew plc, Intuitive Surgical Inc, Karl Storz GmbH And Co KG, Cook Medical Incorporated, Conmed Corporation, Natus Medical Incorporated, Laborie Medical Technologies Corporation, Neoventa Medical AB.
North America was the largest region in the women’s health devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the women’s health devices market report during the forecast period. The regions covered in the women’s health devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the women’s health devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the women’s health devices market by increasing costs of imported electronic components, sensors, diagnostic kits, and device housings. Manufacturers and healthcare providers in North America and Europe are most affected due to reliance on imported device components, while Asia-Pacific faces cost pressures on device manufacturing and exports. These tariffs are raising device prices and slowing product launches. However, they are also encouraging domestic device assembly, regional supply chain development, and increased investment in local femtech innovation ecosystems.
The women’s health devices market research report is one of a series of new reports that provides women’s health devices market statistics, including women’s health devices industry global market size, regional shares, competitors with a women’s health devices market share, detailed women’s health devices market segments, market trends and opportunities, and any further data you may need to thrive in the women’s health devices industry. This women’s health devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Women's health devices encompass a range of tools designed to empower women in managing their health and related data through at-home tests and other features. These devices play a crucial role in enhancing women's healthcare across various aspects, including maternal and menstrual health, pelvic and sexual health, fertility, menopause, contraception, and addressing general health disorders that may affect women differently or disproportionately, such as osteoporosis or cardiovascular disease.
The main types of women's health devices include surgical, diagnostics, contraceptives, labor and delivery, and critical care. Surgical devices are specialized tools used by surgeons to address specific medical conditions. The applications of women's health devices cover areas such as cancer, osteoporosis, infectious diseases, uterine fibroids, post-menopausal syndrome, pregnancy, female sterilization, and more. Various end-users, including hospitals, obstetrics and gynecology clinics, diagnostic laboratories, ambulatory surgical centers, and other healthcare facilities, utilize these devices.
The women’s health devices market consists of sales of contraceptive devices and pharmaceuticals, densitometry, breast implants, obstetrics/gynecology biopsy and imaging. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The women’s health devices market size is expected to see rapid growth in the next few years. It will grow to $77.08 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to increasing investments in femtech innovation, rising demand for personalized healthcare solutions, expansion of telehealth services, growing adoption of wearable health devices, increasing focus on data-driven women’s health insights. Major trends in the forecast period include increasing adoption of connected women’s health devices, rising use of at-home diagnostic kits, growing integration of digital health platforms, expansion of fertility and menstrual tracking solutions, enhanced focus on personalized women’s care.
The rising prevalence of chronic diseases is anticipated to support the expansion of the women’s health devices market in the coming years. Chronic diseases are long-term health conditions that last for extended periods, often develop gradually, negatively impact quality of life, and require continuous medical care, although they can generally be managed through appropriate treatment and lifestyle modifications. The growing burden of chronic diseases is largely attributed to increasingly sedentary lifestyles, which contribute to obesity, impaired metabolic health, and a higher risk of developing long-term medical conditions. Women’s health devices play an important role in addressing chronic conditions by supporting early diagnosis, ongoing monitoring, and customized management of disorders such as diabetes, cardiovascular diseases, and hormonal imbalances, thereby enhancing overall health outcomes and quality of life. For instance, in April 2025, according to a report published by the Centers for Disease Control and Prevention (CDC), a United States-based public health organization, in 2023, 76.4% of adults in the United States, or around 194 million people, reported having at least one chronic condition, with prevalence rates of 59.5% among young adults, 78.4% among middle-aged adults, and 93% among older adults. As a result, the increasing incidence of chronic diseases is contributing to the growth of the women’s health devices market.
Major players in the women’s health devices market are introducing smart rings to deliver medical-grade health data that can be converted into personalized insights for users. These smart rings are specifically developed for women and provide clinically relevant health information through a connected mobile application. For example, in January 2023, Movano Health, a United States-based medical device company, launched Evie, a women-focused smart ring designed to deliver medical-grade health insights via a dedicated app. Evie is developed in line with United States Food and Drug Administration regulatory standards and is manufactured in facilities compliant with International Organization for Standardization 13485 and current Good Manufacturing Practice requirements. The device tracks a wide range of health parameters, including heart rate, blood oxygen saturation (SpO₂), menstrual cycles, sleep patterns, and other metrics, which are displayed in a clear and user-friendly format within the application.
In October 2024, Hologic Inc., a United States-based healthcare technology company focused on women’s health devices, acquired Gynesonics Inc. for approximately $350 million. Through this acquisition, Hologic sought to strengthen its portfolio of minimally invasive gynecological solutions by incorporating an innovative transcervical fibroid treatment technology. Gynesonics Inc., a United States-based medical device company, specializes in the Sonata System, which integrates real-time intrauterine ultrasound imaging with targeted radiofrequency ablation to treat symptomatic uterine fibroids without the need for surgical incisions.
Major companies operating in the women’s health devices market are Abbott Laboratories, Koninklijke Philips N V, CooperSurgical Inc, Hologic Inc, Caldera Medical Inc, GE HealthCare Technologies Inc, Siemens Healthineers AG, Boston Scientific Corporation, Medtronic plc, Becton Dickinson And Company, Olympus Corporation, Fujifilm Holdings Corporation, Johnson And Johnson, Stryker Corporation, Smith And Nephew plc, Intuitive Surgical Inc, Karl Storz GmbH And Co KG, Cook Medical Incorporated, Conmed Corporation, Natus Medical Incorporated, Laborie Medical Technologies Corporation, Neoventa Medical AB.
North America was the largest region in the women’s health devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the women’s health devices market report during the forecast period. The regions covered in the women’s health devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the women’s health devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the women’s health devices market by increasing costs of imported electronic components, sensors, diagnostic kits, and device housings. Manufacturers and healthcare providers in North America and Europe are most affected due to reliance on imported device components, while Asia-Pacific faces cost pressures on device manufacturing and exports. These tariffs are raising device prices and slowing product launches. However, they are also encouraging domestic device assembly, regional supply chain development, and increased investment in local femtech innovation ecosystems.
The women’s health devices market research report is one of a series of new reports that provides women’s health devices market statistics, including women’s health devices industry global market size, regional shares, competitors with a women’s health devices market share, detailed women’s health devices market segments, market trends and opportunities, and any further data you may need to thrive in the women’s health devices industry. This women’s health devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Women's health devices encompass a range of tools designed to empower women in managing their health and related data through at-home tests and other features. These devices play a crucial role in enhancing women's healthcare across various aspects, including maternal and menstrual health, pelvic and sexual health, fertility, menopause, contraception, and addressing general health disorders that may affect women differently or disproportionately, such as osteoporosis or cardiovascular disease.
The main types of women's health devices include surgical, diagnostics, contraceptives, labor and delivery, and critical care. Surgical devices are specialized tools used by surgeons to address specific medical conditions. The applications of women's health devices cover areas such as cancer, osteoporosis, infectious diseases, uterine fibroids, post-menopausal syndrome, pregnancy, female sterilization, and more. Various end-users, including hospitals, obstetrics and gynecology clinics, diagnostic laboratories, ambulatory surgical centers, and other healthcare facilities, utilize these devices.
The women’s health devices market consists of sales of contraceptive devices and pharmaceuticals, densitometry, breast implants, obstetrics/gynecology biopsy and imaging. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Women’s Health Devices Market Characteristics
3. Women’s Health Devices Market Supply Chain Analysis
4. Global Women’s Health Devices Market Trends and Strategies
5. Women’s Health Devices Market Analysis of End Use Industries
7. Global Women’s Health Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Women’s Health Devices Total Addressable Market (TAM) Analysis for the Market
9. Women’s Health Devices Market Segmentation
10. Women’s Health Devices Market Regional and Country Analysis
11. Asia-Pacific Women’s Health Devices Market
12. China Women’s Health Devices Market
13. India Women’s Health Devices Market
14. Japan Women’s Health Devices Market
15. Australia Women’s Health Devices Market
16. Indonesia Women’s Health Devices Market
17. South Korea Women’s Health Devices Market
18. Taiwan Women’s Health Devices Market
19. South East Asia Women’s Health Devices Market
20. Western Europe Women’s Health Devices Market
21. UK Women’s Health Devices Market
22. Germany Women’s Health Devices Market
23. France Women’s Health Devices Market
24. Italy Women’s Health Devices Market
25. Spain Women’s Health Devices Market
26. Eastern Europe Women’s Health Devices Market
27. Russia Women’s Health Devices Market
28. North America Women’s Health Devices Market
29. USA Women’s Health Devices Market
30. Canada Women’s Health Devices Market
31. South America Women’s Health Devices Market
32. Brazil Women’s Health Devices Market
33. Middle East Women’s Health Devices Market
34. Africa Women’s Health Devices Market
36. Women’s Health Devices Market Competitive Landscape and Company Profiles
37. Women’s Health Devices Market Other Major and Innovative Companies
40. Women’s Health Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Women’s Health Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses women’s health devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for women’s health devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The women’s health devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Surgical; Diagnostics; Contraceptives; Labor And Delivery2) By Application: Cancer; Osteoporosis; Uterine Fibroids; Post-menopausal Syndrome; Pregnancy; Female Sterilization; Other Applications
3) By End-user: Hospitals; Obstetrics And Gynecology Clinics; Diagnostic Laboratories; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Surgical: Hysteroscopes; Endometrial Ablation Devices2) By Diagnostics: Pap Smear Devices; Hormone Testing Kits
3) By Contraceptives: Intrauterine Devices (IUDs); Implantable Contraceptives
4) By Labor and Delivery: Fetal Monitors; Obstetric Ultrasound Machines; Labor Induction Devices
Companies Mentioned: Abbott Laboratories; Koninklijke Philips N V; CooperSurgical Inc; Hologic Inc; Caldera Medical Inc; GE HealthCare Technologies Inc; Siemens Healthineers AG; Boston Scientific Corporation; Medtronic plc; Becton Dickinson And Company; Olympus Corporation; Fujifilm Holdings Corporation; Johnson And Johnson; Stryker Corporation; Smith And Nephew plc; Intuitive Surgical Inc; Karl Storz GmbH And Co KG; Cook Medical Incorporated; Conmed Corporation; Natus Medical Incorporated; Laborie Medical Technologies Corporation; Neoventa Medical AB
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Women’s Health Devices market report include:- Abbott Laboratories
- Koninklijke Philips N V
- CooperSurgical Inc
- Hologic Inc
- Caldera Medical Inc
- GE HealthCare Technologies Inc
- Siemens Healthineers AG
- Boston Scientific Corporation
- Medtronic plc
- Becton Dickinson And Company
- Olympus Corporation
- Fujifilm Holdings Corporation
- Johnson And Johnson
- Stryker Corporation
- Smith And Nephew plc
- Intuitive Surgical Inc
- Karl Storz GmbH And Co KG
- Cook Medical Incorporated
- Conmed Corporation
- Natus Medical Incorporated
- Laborie Medical Technologies Corporation
- Neoventa Medical AB
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 49.48 Billion |
| Forecasted Market Value ( USD | $ 77.08 Billion |
| Compound Annual Growth Rate | 11.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
